Objective: In routine practice, axillary lymph node dissection is performed in early invasive breast cancer patients with positive sentinel node biopsy. However, sentinel node is the only involved axillary node in 40-70% of patients, and determining factors that predict axillary non-sentinel node involvement will therefore prevent unnecessary axillary lymph node dissection and decrease morbidity.
performed with cytokeratin AE1/AE3 (Dako, Glostrup, Denmark). The microanatomic location of metastatic deposits within each SN was classified as subcapsular, parenchymal, combined subcapsular and parenchymal (single focus), multifocal or extensive (14) . Multifocality was defined as two or more separated metastatic deposits at some distance from each other, whereas extensive SN involvement was defined as any metastasis >5mm in diameter, or any node with extracapsular spread (14, 15) .
The largest diameter of the metastasis in each SN was measured from the slide with an ocular micrometer. If more than one deposit of tumor was found in a SN, or if multiple SNs were positive, the size of the largest tumor deposit was recorded. The size of the tumor was classified according to the International Union Against Cancer (UICC) classification as follows: isolated tumor cells (solitary tumor cells or tumor cell clusters with a size of 0.2 mm or less), micrometastasis (tumor with a size of 0.2-2 mm), and macrometastasis (tumor greater than 2 mm in size) (16) .
The area of metastatic tumor was calculated by multiplying the largest two dimensions of the tumor. In cases with more than one metastatic focus, the area of each focus was measured separately and were added to each other. The surface area of each lymph node was calculated by multiplying the largest two dimensions of the lymph node. The ratio of the total metastatic tumor area to the largest surface area of the lymph node was multiplied by 100, and the percentage of area replaced by tumor was obtained.
The relationship between positivity of non-SN and the predictive factors was assessed using Pearson chi-square test for categorical variables. Characteristics that were found to be significant by univariate analysis were then entered in a backward stepwise method in a logistical regression analysis to develop a multivariate model of independent factors, for predicting the presence of positive non-SNs. All statistical analyses were performed using SPSS for Windows 11.0. P values of ≤0.05 were considered to be statistically significant.
RESULtS
A total of 119 female patients with primary invasive breast cancer and SN metastasis were analyzed in this study. Patient and tumor characteristics are shown in Table I . The mean age of the patients was 50.7 years (range, 28-80 years). Histological type of the primary tumor was invasive ductal carcinoma in 43 patients (36.1%), invasive lobular carcinoma in 25 patients (21.0%), and mixed invasive breast carcinoma in 51 patients (42.9%). The majority of the patients (90.8%) had peritumoral lymphovascular invasion. The size of the primary tumor was calculated
INtRODUCtION
The most important prognostic factor in primary invasive breast cancer is the status of the axillary lymph nodes. Sentinel lymph node (SN) biopsy has become the routine surgical procedure for axillary nodal staging, particularly in patients with early-stage invasive breast cancer. Currently, axillary lymph node dissection (ALND) is performed only in patients with positive SN. However, it is well known that the SN is the only involved axillary node in 40-70% of patients (1) (2) (3) (4) . Moreover, the therapeutic effect of axillary radiation therapy and systemic chemotherapy in patients with metastatic SN also questions the true benefit of ALND that has many morbidities for the patient (2, 5) .
Primary tumor size, presence of peritumoral lymphovascular invasion, size of the SN metastasis, number of positive SNs, the ratio of positive SNs to all identified SNs, and extracapsular extension have been reported to be strongly associated with non-SN status (1, (6) (7) (8) (9) (10) . However, none of these factors alone have been proven to be helpful in distinguishing patients who are suitable or not for further ALND. Although a number of scoring systems and nomograms, that predict non-SN status in patients with invasive breast cancer and SN metastasis have been developed, these prediction models need to be validated before being used in routine practice (6, (11) (12) (13) .
In our study, we reviewed the slides of patients with invasive breast cancer who have positive SNs, with the aim of determining whether micromorphometric features and tumor load of positive SNs are useful for predicting non-SN status in early breast cancer patients. We also evaluated the correlation of primary tumor characteristics with non-SN metastasis in these patients.
MAtERIAL and MEtHOD
One hundred and nineteen invasive breast cancer patients with a positive SN biopsy, who underwent subsequent ALND at Dokuz Eylul University Faculty of Medicine, between January 1998 and December 2009, were included in this study. The original hematoxylin-eosin (H&E) slides and pathology reports were reviewed for primary tumor size, histologic type of tumor, and presence of peritumoral lymphovascular invasion.
SN biopsy was performed with radioisotope and/or blue dye injection, as previously described (6) . SNs were bisected if less than 5 mm or sliced at 2-3 mm intervals if greater than 5 mm. ALND was performed in patients with positive SNs diagnosed with cytology imprint and/or frozen section. The number of SNs removed and number of positive SNs were recorded. SNs were examined by both conventional histology and immunohistochemistry (IHC). IHC was in 104 patients (87.4%), whereas in 15 consultation cases (12.6%) with outside excision, the exact size of the primary tumor could not be obtained. The mean size of the primary tumor in 104 patients was 21.6 mm (range, 2-54 mm). There was no significant statistical correlation between age of the patients (p=0.676), histological type (p=0.277) and size of the primary tumor (p=0.931) and the presence of non-SN metastasis.
Most cases were either pT1 (53 patients, 44.5%) or pT2 (64 patients, 53.8%). Non-SN metastasis was detected in 27 patients (41.5%) with pT1 and 36 patients (55.5%) with pT2 tumor. There was no statistically significant difference between these two groups in terms of non-SN metastasis (p=0.582). There was 1 patient (1.5%) with pT3, and 1 patient (1.5%) with pT4 tumor who had non-SN metastasis.
SN biopsy was performed in all patients. SN and non-SN characteristics of the patients are listed in Table II . The total number of SNs per patient varied from 1 to 7. The number of metastatic SNs per patient ranged from 1 to 4. Sixty-five patients (54.6%) had metastatic tumor in the non-SNs, whereas in 54 patients (45.4%) there was no metastasis in the non-SNs. The mean number of non-SNs obtained with axillary dissection per patient was 14.6 (range, . The number of metastatic non-SNs per patient ranged from 1 to 18.
Features of the metastatic tumor in the SNs, such as the microanatomic location and size of the tumor, and the ratio of the metastatic tumor area to the total lymph node area were evaluated. The metastatic deposits were subcapsular in 16 patients (13.4%), parenchymal in 10 patients (8.4%), subcapsular and parenchymal as a single focus in 25 patients (21.0%), multifocal in 25 patients (21.0%), and extensive in 43 patients (36.1%) (Figures 1-5 ).
Two patients (1.7%) had isolated tumor cell clusters (<0.2 mm) in the SNs, 14 patients (11.8%) had micrometastasis (0.2-2 mm), and 103 patients (86.6%) had macrometastasis (>2 mm). In 46 patients (38.7%) the metastatic tumor load in the SNs was ≤ 25%, in 20 patients (16.8%) it was between 26-50%, and in 53 patients (44.5%) the tumor load was >50%.
In univariate analysis, the microanatomic location of SN metastasis correlated significantly with non-SN inolvement (p=0.002). Patients with subcapsular, parenchymal, combined subcapsular and parenchymal, multifocal, and extensive tumor deposits showed non-SN involvement in 12.3%, 3.1%, 20.0%, 13.8%, and 50.8% of the cases, respectively. The ratio of metastatic tumor area to the total SN area (p<0.001), and the total number of SNs removed (p=0.041) were also significantly associated with the presence of metastasis in the non-SNs. The tumor load in the SNs was ≤ 25% in 31 patients (57.4%) with no further metastasis in the non-SNs, whereas 40 patients (61.5%) with metastasis in the non-SNs had tumor load >50% in the SNs. Patients were further grouped into two, as patients in whom only one SN was removed, as opposed to those with more than one SN removed; 68.8% of patients with only one SN removed had nodal metastases in non-SNs, versus 45.1% of those with multiple SNs resected (p=0.015).
In multivariate analysis, the ratio of metastatic tumor area to the total SN area, ie. the area percent of SN occupied by tumor (p<0.001), and the number of total SNs removed (p=0.033) remained significantly associated with non-SN involvement. Table III summarizes the results of the statistical analyses to determine the relationship between clinicopathologic variables and positive non-SNs.
DISCUSSION
Our findings indicate that the area percent of SN occupied by tumor, and the total number of SNs removed predict the presence of non-SN metastasis in patients with invasive breast cancer. The size of the metastatic tumor in SNs has been proven to be a predictor of non-SN involvement by many studies using multivariate analyses (6, 7, 15, 17, 18) . Other factors considering tumor burden in SNs, such as percent replacement of SN by tumor, the number of positive SNs, the proportion of involved SNs among all identified SNs, and presence of extracapsular extension have also been shown to be predictors of non-SN involvement by different studies (2, 8, (10) (11) (12) 17, (19) (20) (21) (22) . These findings have encouraged researchers to find out simple methods to evaluate the tumor burden in SNs. Farshid et al. were the first to consider the proportion of SN replaced by metastasis (23) . They have found out that proportion of SN replaced by metastasis, as well as the age of the patient and the number of SNs were independent predictors of non-SN status. Van Deurzen et al., on the other hand, have used morphometric analysis in order to accurately assess the tumor load in SNs, and have reported that the frequency of second echelon lymph node metastases in patients with area *Lymphovascular invasion could not be determined in 2 outside patients. **Combined subcapsular and parenchymal (single focus).
percent of SN occupied by tumor <6%, between 6-80%, and >80% was 20%, 46%, and 75%, respectively (22) . They have emphasized that no subgroup of patients could be identified with less than 20% of non-SN involvement, concluding that the area percent of SN occupied by tumor was the only independent factor in predicting second echelon lymph node involvement (p<0.001) (22) .
In the present study, the area percent of SN occupied by tumor was ≤25% in 46 patients (38.7%). The majority of these patients (67.4%) did not have metastasis in their non-sentinel axillary lymph nodes. On the other hand, 40 (75.5%) of 53 patients with a tumor burden >50% in SNs had non-SN involvement (p<0.001). Patients with a tumor burden ≤25% were either pT1 (50%) or pT2 (50%). The only patients with pT3 and pT4 tumor had a tumor burden >50% in their SNs. Although not statistically significant (p=0.693), this finding supports many studies that suggest size of primary tumor to be a positive predictor of non-SN involvement (1, (24) (25) (26) .
The number of total SNs removed as well as the number of positive and negative SNs have been evaluated by various studies (6, 15, 17, 22, 23) . Most studies have reported the number of positive SNs to be a positive predictor of non-SN involvement (17, 27, 28 In the present study, microanatomic location of metastasis in SNs (p=0.002) was shown to be a significant positive predictor of residual axillary involvement, only with univariate analysis. Recently, some studies have reported significant correlation between microanatomic location of metastasis in SNs and non-SN involvement, both in breast cancer and malignant melanoma (14, 15, 29) . In this study, we generated 5 groups according to the microanatomic location of metastasis in SNs: subcapsular, parenchymal, subcapsular and parenchymal as a single focus, multifocal and extensive metastasis. Thirty-three out of 43 patients (76.7%) with extensive SN metastasis had further axillary involvement, which is in accordance with van Deurzen et al. 's study (15) .
Among studies that have reported significant correlation between size of metastasis in SNs and presence of non-SN involvement, the majority emphasizes that the chance of non-SN involvement decreases with the presence of isolated tumor cell clusters (≤ 0.2 mm) and/or micrometastasis (0.2-2 mm) (1, 4, 8, 19) . In our study, 1 of 2 patients with isolated tumor cells, and 5 of 14 patients with micrometastases had non-SN involvement (p=0.312). There are also studies that have investigated patients in whom ALND was not performed after finding micrometastasis in SNs, and they did not find any significant difference between patients, in terms of prognosis (30, 31) . However, because up to 53% of patients with micrometastasis in SNs have non-SN metastasis, it is emphasized by van Deurzen et al., that macrometastases may arise in non-SNs of patients with micrometastasis or even isolated tumor cells in SNs (22) .
In conclusion, increasing tumor burden in the SNs is a significant predictor of non-SN involvement. This study confirms that the area percent of SN occupied by tumor, as well as the total number of SNs excised are independent predictors of axillary metastasis. Further studies with larger patient populations are required to find out easier methods to evaluate the tumor burden in SNs accurately, and to detect distinct parameters which can spare patients who undergo ALND with no therapeutic benefit.
